BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34613870)

  • 21. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.
    Rabe IB; Miller ER; Fischer M; Hills SL
    Vaccine; 2015 Jan; 33(5):708-12. PubMed ID: 25498208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
    Srivastava AK; Putnak JR; Lee SH; Hong SP; Moon SB; Barvir DA; Zhao B; Olson RA; Kim SO; Yoo WD; Towle AC; Vaughn DW; Innis BL; Eckels KH
    Vaccine; 2001 Aug; 19(31):4557-65. PubMed ID: 11483284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.
    Wei J; Wang X; Zhang J; Guo S; Pang L; Shi K; Liu K; Shao D; Qiu Y; Liu L; Widén F; Li B; Ma Z
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007601. PubMed ID: 31374086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response at 12-23 months following a single dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
    Krow-Lucal ER; Laven J; Perry L; Biggerstaff BJ; Johnson BW; Hollis E; Fischer M; Woolpert T; Hills SL
    Vaccine; 2020 Oct; 38(44):6899-6903. PubMed ID: 32907756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Japanese encephalitis vaccines: current vaccines and future prospects.
    Monath TP
    Curr Top Microbiol Immunol; 2002; 267():105-38. PubMed ID: 12082985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on Japanese encephalitis vaccine for children: United States, May 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):664-5. PubMed ID: 21617633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new inactivated Japanese encephalitis vaccine for adult travelers.
    Toovey S
    Travel Med Infect Dis; 2009 Sep; 7(5):301-4. PubMed ID: 19747666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016.
    Walker WL; Hills SL; Miller ER; Fischer M; Rabe IB
    Vaccine; 2018 Jul; 36(29):4369-4374. PubMed ID: 29891351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese encephalitis vaccines: moving away from the mouse brain.
    Zanin MP; Webster DE; Martin JL; Wesselingh SL
    Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Japanese encephalitis: new options for active immunization.
    Halstead SB; Thomas SJ
    Clin Infect Dis; 2010 Apr; 50(8):1155-64. PubMed ID: 20218889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advances in research of interchangeable immunization with live attenuated Japanese encephalitis vaccines and inactivated vaccines].
    Deng X; He HQ; Zhou Y; Yan R; Tang XW; Zhu Y; Xu XP; Lyu HK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):554-560. PubMed ID: 35644967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial.
    Yun KW; Lee HJ; Kang JH; Eun BW; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
    BMC Infect Dis; 2015 Jan; 15():7. PubMed ID: 25567119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine.
    Furuya-Kanamori L; Gyawali N; Mills DJ; Mills C; Hugo LE; Devine GJ; Lau CL
    J Travel Med; 2023 Apr; 30(2):. PubMed ID: 36308439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).
    Appaiahgari MB; Vrati S
    Expert Opin Biol Ther; 2012 Sep; 12(9):1251-63. PubMed ID: 22775524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative frequency of specified adverse events following Vero cell culture-derived Japanese encephalitis and Vi capsular polysaccharide typhoid vaccines in U.S. military personnel, July 2011-August 2019.
    Seshadri S; Martin SW; Hills SL; Collins LC
    Vaccine; 2023 Feb; 41(9):1537-1540. PubMed ID: 36725428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.
    Erra EO; Askling HH; Rombo L; Riutta J; Vene S; Yoksan S; Lindquist L; Pakkanen SH; Huhtamo E; Vapalahti O; Kantele A
    Clin Infect Dis; 2012 Sep; 55(6):825-34. PubMed ID: 22696017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
    Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.